SCHEMBL157376

SCHEMBL157376

COc1cc(C(=O)NS(=O)(=O)c2ccccc2C)ccc1Cc1cn(C)c2ccc(C(=O)NC[C@H](C)CC(F)(F)F)cc12

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30494611 1.00
SCHEMBL30494589 1.00
SCHEMBL157377 1.00
SCHEMBL8427210 0.90
SCHEMBL9472459 0.86
SCHEMBL9472457 0.86
SCHEMBL8532662 0.86
SCHEMBL9293941 0.86
SCHEMBL8533700 0.86
SCHEMBL8532769 0.85

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 262 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023110843-A1 HETEROBICYCLIC DERIVATIVES AS ITK INHIBITORS ALMIRALL, S.A. (ES) 2023-06-22 WO claimed
EP-0531078-B1 (R)-3-Methoxy-4- 1-methyl-5-(2-methyl-4,4,4-trifluorobutylcarbamoyl)indol-3-ylmethyl -N-(2-methylsulphonyl)benzamide in crystalline form ZENECA LTD (GB) 1996-06-05 EP claimed
US-5466826-A Crystallization of indole derivative from solvents as antiasthmatics IMPERIAL CHEMICAL INDUSTRIES, PLC (GB) 1995-11-14 US claimed
EP-0489548-B1 A process for the preparation of 2(R)-methyl-4,4,4-trifluorobutylamine, intermediates, and a process for the preparation of a derivative thereof ZENECA LTD (GB) 1994-12-14 EP claimed
US-5352694-A 3-methoxy-4(1-methyl-5(2-methyl-4,4,4-trifluorobutylcarbamoyl) indole-3-ylmethyl)-N-(2-methylphenylsulphonyl) benzamide; leukotriene antagonist used for asthma treatment IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1994-10-04 US claimed
US-5274118-A Process for preparing (2R)-methyl-4,4,4-trifluorobutylamine IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1993-12-28 US claimed
US-12629379-B2 Pharmaceutical composition for preventing, suppressing, or treating symptom associated with allergic reaction NIPPON CHEMIPHAR CO., LTD. (JP) 2026-05-19 US disclosed
EP-4359402-B1 IMIDAZOLO INDAZOLE COMPOUNDS AS JAK INHIBITORS THERAVANCE BIOPHARMA R&D IP LLC (US) 2026-03-11 EP disclosed
EP-3985126-B1 NON-INVASIVE DIAGNOSTIC OF NON-ALCOHOLIC STEATOHEPATITIS GENFIT (FR) 2026-03-04 EP disclosed
EP-4355915-B1 METHOD FOR NASH RISK ASSESSMENT IN PATIENTS HAVING A METABOLIC DISORDER GENFIT (FR) 2026-02-04 EP disclosed
US-20260000678-A1 PHARMACEUTICAL COMPOSITION FOR PREVENTING, SUPPRESSING, OR TREATING SYMPTOM ASSOCIATED WITH PSEUDO-ALLERGIC REACTION TAKASAKI UNIV OF HEALTH AND WELFARE (JP) 2026-01-01 US disclosed
EP-3643309-B1 NINTEDANIB FOR USE IN THE TREATMENT OF SYSTEMIC SCLERODERMA BOEHRINGER INGELHEIM INT (DE) 2025-12-03 EP disclosed
US-12485088-B2 Rapidly-orodispersible tablets having an interior cavity Aprecia Pharmaceuticals LLC (US) 2025-12-02 US disclosed
US-5334765-A Intermediate for leukotriene antagonists IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1994-08-02 US disclosed
US-5286740-A Leukotrine antagonists; antiinflammatory agnets, antiallergens, treating asthma IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1994-02-15 US disclosed
US-5280125-A Chemical process for the preparation of 3-alkylated indole IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1994-01-18 US disclosed
US-5274118-A Process for preparing (2R)-methyl-4,4,4-trifluorobutylamine IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1993-12-28 US disclosed
US-5274118-A Process for preparing (2R)-methyl-4,4,4-trifluorobutylamine IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1993-12-28 US disclosed
EP-0489548-A1 A process for the preparation of 2(R)-methyl-4,4,4-trifluorobutylamine, intermediates, and a process for the preparation of a derivative thereof ZENECA LIMITED (GB) 1992-06-10 EP disclosed
EP-0489547-A1 A process for the preparation of a 3-alkylated indole, intermediates, and a process for the preparation of a derivative thereof ZENECA LIMITED (GB) 1992-06-10 EP disclosed